In-Vitro Combo Treatments of Human Melanoma Cell Lines (BLM, 1205Lu, WM238)   with Curcumin, Steroids and Vitamins

Authors

  • Pandurangan Ramaraj Professor of Biochemistry Dept. of Biomedical Sciences, Baptist University College of Osteopathic Medicine, USA Author

DOI:

https://doi.org/10.47363/dd713c28

Keywords:

Combo Treatments, Human Melanoma, Vitamins

Abstract

Results of our previous in-vitro studies on the inhibition of human melanoma cell growth by steroids (progesterone (P), RU-486), 
curcumin (cur) and vitamins (A and D3), gave the idea for a combination treatment of melanoma cells in-vitro. The aim was to 
study the combined effects of curcumin, vitamins (D3 and A), and steroids (P4 and RU-486) on human melanoma (BLM, 1205Lu, 
WM238) cell growth and interleukin-8 (IL-8) secretion in vitro. Human melanoma cells were incubated in a 96-well plate with 
a single (solo) compound or a double combo of the compounds or a triple combo of the compounds in various combinations. 
Supernatants were subjected to Elisarray and quantitation of the cytokine IL-8 secreted by the cells. Results from the three cell lines 
(BLM, 1205Lu and WM238) were compared. Solo or single compound treatment of Cur, P, RU, A and D3 resulted in 40 to 57% 
of BLM cell growth compared to its untreated control cell growth at 100%. Similarly, 1205Lu cell line treatments resulted in 37 to 
59% cell growth compared to its untreated control cell growth at 100%. A double combo of compounds such as Cur+D3, Cur+P 
treatments resulted in 19 to 42% of BLM cell growth and 17 to 37% of 1205Lu cell growth. Whereas WM238 cell line showed 18 to 22% cell growth. A triple combo such as Cur+P+RU, treatments resulted in 21 to 30% of BLM cell growth and 19 to 30% of 1205Lu cell growth. Whereas WM238 cell line showed 19 to 20% cell growth. Elisarray of the supernatants pointed to the two combo treatments A+RU and Cur+P+RU as having a basal secretion profile of various proinflammatory cytokines by the three cell lines with IL-8 secretion significantly suppressed. Hence, IL-8 in the supernatants of the two combo treatments was quantitated by Elisa. IL-8 secretion by the BLM cell line was 46.1 pg/ml and 31.08 pg/ml respectively in the supernatants of the combos A+RU and Cur+P+RU. Whereas IL-8 secretion by the 1205Lu cell line was 17.5 and 8.0 pg/ml respectively and IL-8 secretion by the WM238 cell line was 0.515 and 0.926 pg/ml respectively. 

Author Biography

  • Pandurangan Ramaraj, Professor of Biochemistry Dept. of Biomedical Sciences, Baptist University College of Osteopathic Medicine, USA

    Pandurangan Ramaraj, Professor of Biochemistry Dept. of Biomedical Sciences, Baptist University College of Osteopathic Medicine, USA

Downloads

Published

2025-05-08